March 24, 2023
D.C. News | Tea Leaves
  • The US government is setting more goals around biomanufacturing efforts, with a vision for stronger supply chains and greater domestic production. A report released by The White House yesterday lays out “bold goals,” including an aim to produce at least a quarter of all active pharmaceutical ingredients in the U.S. for small-molecule drugs within five years. While some of the report is centered around climate change and agricultural initiatives, it also presents goals for health and supply chain resilience. (Article here; Report here)